JP2023540094A5 - - Google Patents
Info
- Publication number
- JP2023540094A5 JP2023540094A5 JP2023514415A JP2023514415A JP2023540094A5 JP 2023540094 A5 JP2023540094 A5 JP 2023540094A5 JP 2023514415 A JP2023514415 A JP 2023514415A JP 2023514415 A JP2023514415 A JP 2023514415A JP 2023540094 A5 JP2023540094 A5 JP 2023540094A5
- Authority
- JP
- Japan
- Prior art keywords
- raav
- pharmaceutical composition
- capsid protein
- vegf
- mir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074361P | 2020-09-03 | 2020-09-03 | |
| US63/074,361 | 2020-09-03 | ||
| US202163179700P | 2021-04-26 | 2021-04-26 | |
| US63/179,700 | 2021-04-26 | ||
| PCT/US2021/048917 WO2022051537A1 (en) | 2020-09-03 | 2021-09-02 | Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540094A JP2023540094A (ja) | 2023-09-21 |
| JP2023540094A5 true JP2023540094A5 (https=) | 2024-09-06 |
Family
ID=80491540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514415A Pending JP2023540094A (ja) | 2020-09-03 | 2021-09-02 | Ｋｈ９０２（コンベルセプト）の送達のためのアデノ随伴ウイルスおよびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230340529A1 (https=) |
| EP (1) | EP4208478A4 (https=) |
| JP (1) | JP2023540094A (https=) |
| KR (1) | KR20230061441A (https=) |
| AU (1) | AU2021336425A1 (https=) |
| BR (1) | BR112023003548A2 (https=) |
| CA (1) | CA3192736A1 (https=) |
| IL (1) | IL300864A (https=) |
| MX (1) | MX2023002695A (https=) |
| WO (1) | WO2022051537A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3727468A4 (en) | 2017-12-19 | 2021-09-22 | Akouos, Inc. | AAV-MEDIATED THERAPEUTIC ANTIBODIES DELIVERY TO THE INTERNAL EAR |
| IL303317A (en) | 2020-12-01 | 2023-07-01 | Akouos Inc | ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA |
| CN121263523A (zh) * | 2023-03-28 | 2026-01-02 | 通用药品有限责任公司 | 核酸关闭开关及其方法和用途 |
| WO2024220389A2 (en) * | 2023-04-17 | 2024-10-24 | University Of Massachusetts | Aav2 variants and uses thereof |
| WO2025061000A1 (zh) * | 2023-09-21 | 2025-03-27 | 成都弘基生物科技有限公司 | 一种用于治疗受试者中与血管新生相关的眼病的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1767546B1 (en) * | 2004-06-08 | 2012-03-07 | Chengdu Kanghong Biotechnologies Co., Ltd. | Angiogenesis-inhibiting chimeric protein and the use |
| DK4374873T3 (da) * | 2013-07-12 | 2025-11-03 | Astellas Us Llc | Middel til brug ved behandling eller forebyggelse af oftalmologiske tilstande |
| WO2015164786A1 (en) * | 2014-04-25 | 2015-10-29 | University Of Massachusetts | Recombinant aav vectors useful for reducing immunity against transgene products |
| US11046955B2 (en) * | 2015-04-24 | 2021-06-29 | University Of Massachusetts | Modified AAV constructs and uses thereof |
| ES2840059T3 (es) * | 2016-06-16 | 2021-07-06 | Adverum Biotechnologies Inc | Tratamiento de la DMRE mediante el uso de la variante AAV2 con aflibercept |
| JP2020510424A (ja) * | 2017-02-28 | 2020-04-09 | アドヴェラム バイオテクノロジーズ， インコーポレイテッド | 改変ａａｖカプシドおよびその使用 |
| AU2018350990A1 (en) * | 2017-10-18 | 2020-05-21 | Regenxbio Inc. | Treatment of ocular diseases and metastatic colon cancer with human post-translationally modified VEGF-Trap |
| KR102205830B1 (ko) * | 2017-10-26 | 2021-01-21 | 주식회사 큐로진생명과학 | 솔루블 VEGFR-1 변이체 cDNA를 함유하는 rAAV를 포함하는 황반변성 치료용 조성물 |
| DK4364724T3 (da) * | 2018-05-10 | 2025-12-22 | Regeneron Pharma | Formuleringer med høj koncentration af VEGF-receptorfusionsprotein |
-
2021
- 2021-09-02 CA CA3192736A patent/CA3192736A1/en active Pending
- 2021-09-02 WO PCT/US2021/048917 patent/WO2022051537A1/en not_active Ceased
- 2021-09-02 IL IL300864A patent/IL300864A/en unknown
- 2021-09-02 JP JP2023514415A patent/JP2023540094A/ja active Pending
- 2021-09-02 US US18/024,359 patent/US20230340529A1/en active Pending
- 2021-09-02 AU AU2021336425A patent/AU2021336425A1/en active Pending
- 2021-09-02 EP EP21865133.9A patent/EP4208478A4/en active Pending
- 2021-09-02 BR BR112023003548A patent/BR112023003548A2/pt unknown
- 2021-09-02 MX MX2023002695A patent/MX2023002695A/es unknown
- 2021-09-02 KR KR1020237010791A patent/KR20230061441A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540094A5 (https=) | ||
| Bordet et al. | Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives | |
| JP7814430B2 (ja) | 深部イントロン突然変異の遺伝子編集 | |
| US12442015B2 (en) | Closed-ended DNA vectors obtainable from cell-free synthesis and process for obtaining ceDNA vectors | |
| US11851657B2 (en) | Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization | |
| JP2023123765A (ja) | 中枢神経系を標的化したａａｖベクター | |
| JP2019000114A (ja) | 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター | |
| JP2022529775A5 (https=) | ||
| CA3130515A1 (en) | Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp) | |
| US20210371480A1 (en) | Compositions and methods for treating age-related macular degeneration and other diseases | |
| JP2017500060A (ja) | 対象の網膜色素上皮において目的のポリヌクレオチドを発現させるための方法および医薬組成物 | |
| US20260001917A1 (en) | Modified adeno-associated virus capsid proteins and methods thereof | |
| Allocca et al. | AAV-mediated gene transfer for retinal diseases | |
| JP2025114604A (ja) | 眼疾患の遺伝子治療 | |
| CA3088079A1 (en) | Compositions and methods for treating retinal disorders | |
| US12270033B2 (en) | Dual leucine zipper kinase inhibitors for gene therapy | |
| CN112424368A (zh) | 用于调节眼内压和颅内压的材料和方法 | |
| WO2021076794A1 (en) | Methods for modulating level of expression from gene therapy expression cassette | |
| US20250025575A1 (en) | Compositions and Methods for Cell-Specific Expression of Target Genes | |
| CN117736274A (zh) | 一种腺相关病毒衣壳蛋白及其用途 | |
| CN115997012B (zh) | Rpe65相关眼睛疾病和障碍的治疗 | |
| CN118146317A (zh) | 一种腺相关病毒衣壳蛋白及其用途 | |
| HK40036018A (en) | Compositions and methods for treating age-related macular degeneration |